SYDNEY, August 16, 2012-Elsevier, a world-leading provider of scientific, technical, and medical information products and services, is proud to announce the launch of Performance Enhancement & Health - a new international, peer-reviewed journal that critically explores the health implications of performance enhancement on the human being, from steroid doping in elite athletes, right through to amphetamine use amongst truck drivers.
Performance Enhancement & Health boasts a wide-ranging appeal that extends from social scientists through to healthcare workers and, of course, those working in physical or sporting fields. As a multidisciplinary journal it provides fascinating food for thought. With the 2012 Olympic Games only just ended, the debate continues over performance enhancement in sport.
Performance enhancement is not only unique to athletes however. Performance enhancement can be pharmacological, genetic, psychological or technological and may be linked to identity, social capital or pleasure, as well as productivity. Health is envisaged broadly as absence of disease, optimal functioning, and (personal or community) well-being. Performance Enhancement & Health therefore examines the implications of performance enhancement on the human condition - both in the sporting arena and beyond.
The journal's co-editors, Dr Jason Mazanov of the University of New South Wales and Associate Professor Frances Quirk of James Cook University, identified the need for a specific forum for scholars to discuss the role and impact of performance enhancement in society.
Mazanov and Quirk's aims in producing Performance Enhancement & Health include exploring how the effort to enhance our human condition has influenced health, and developing a more worldly understanding of the performance enhancement-health nexus.
PR Newswire